Liquidia (LQDA)
Commercializes inhaled treprostinil therapies for pulmonary hypertension and develops twice-daily L606.
$67.17
vs last close−1.47 (−2.15%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 40 days
EPS estimate
$0.90
Revenue estimate
$205.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.46−$0.45−$0.49−$0.04$0.15$0.52$0.74Pending
Estimate−$0.38−$0.42−$0.43−$0.45$0.08$0.34$0.76$0.90
Surprise−21.1%−7.1%−14.0%+91.1%+87.5%+52.9%−2.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$2.9M$3.1M$8.8M$54.3M$92.0M$132.9M$171.7MPending
Estimate$3.3M$4.2M$14.3M$80.7M$88.6M$119.4M$168.5M$205.9M
Surprise−12.0%−25.0%−38.2%−32.7%+3.9%+11.2%+1.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.55 | — | — |
| Sep 2027 | $1.55 | — | — |
| Jun 2027 | $1.40 | — | — |
| Mar 2027 | $1.23 | — | — |
| Dec 2026 | $0.94 | — | — |
| Nov 2026 | $0.90 | — | — |
| Aug 2026 | $0.76 | $0.74 | −2.4% |
| May 2026 | $0.34 | $0.52 | +52.9% |
| Mar 2026 | $0.08 | $0.15 | +87.5% |
| Nov 2025 | −$0.45 | −$0.04 | +91.1% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| Jul 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.55 | — | — | $359.3M | — | — | — |
| Sep 2027 | $1.55 | — | — | $321.4M | — | — | — |
| Jun 2027 | $1.40 | — | — | $296.8M | — | — | — |
| Mar 2027 | $1.23 | — | — | $264.6M | — | — | — |
| Dec 2026 | $0.94 | — | — | $228.5M | — | — | — |
| Nov 2, 2026 | $0.90 | — | — | $205.9M | — | — | — |
| Aug 12, 2026 | $0.76 | $0.74 | −2.4% | $168.5M | $171.7M | +1.9% | −10.5% |
| May 11, 2026 | $0.34 | $0.52 | +52.9% | $119.4M | $132.9M | +11.2% | +25.6% |
| Mar 5, 2026 | $0.08 | $0.15 | +87.5% | $88.6M | $92.0M | +3.9% | +0.4% |
| Nov 3, 2025 | −$0.45 | −$0.04 | +91.1% | $80.7M | $54.3M | −32.7% | +3.5% |
| Aug 12, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 19, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 23, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 11, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Oct 31, 2018 | |||||||
| Aug 14, 2018 | |||||||
| Jul 26, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |